Open-source Java projects advance Jakarta EE compatibility, persistence capabilities, and developer tooling as enterprise teams prepare for the next generation of Java applications.

Need to install Java on your Mac to run a particular application? While most Mac users will never need Java, there are certain apps, development tools, enterprise software, and utilities that still ...

BRUSSELS, April 14, 2026 (GLOBE NEWSWIRE) -- The Eclipse Foundation today announced the Open VSX Security Researcher Recognition Program, a new initiative designed to strengthen the security of the ...

It’s not every day that Butler County and the surrounding region stands in the epicenter of something as exciting as a solar eclipse. But what that means for astronomy enthusiasts as well as plants, ...

Recently, a friend asked me a question that's been floating around every boardroom and business school: "With AI writing code, does programming still matter?" It's a fair question. Generative AI can ...

Community driven content discussing all aspects of software development from DevOps to design patterns. When the seminal Java whitepaper introduced the language in 1995, it listed seven key benefits ...

ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...

Community driven content discussing all aspects of software development from DevOps to design patterns. All you need to do is open an online editor and code away! Which is exactly what we’re going to ...

Java Development Kit (JDK) 24 is now available as a production release. A short-term support release of standard Java, JDK 24 will receive only six months of Premier-level support from Oracle, ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first patient in its Phase 3 ECLIPSE registrational program. The ECLIPSE registrational ...